Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-9-22
pubmed:abstractText
The large secreted glycoprotein thrombospondin-1 is a potent inhibitor of neovascularization in vivo. In order to better understand its mechanism of action, we have determined the full range of deficits thrombospondin can impose on cultured capillary endothelial cells. Exogenously added thrombospondin-1 blocked the ability of these cells to organize into cords. It blocked the migration of endothelial cells and vascular smooth muscle cells, but not that of fibroblasts, neutrophils, or keratinocytes, demonstrating specificity. Conversely, when the endogenous thrombospondin-1 produced by the endothelial cells was inactivated using antibodies that can neutralize its inhibition of neovascularization in vivo, migration toward basic fibroblast growth factor and cord formation were stimulated, and sparsely plated cells developed cylindrical cavities. These cavities formed by vesicle fusion, extended the depth of the cell, and appeared to be incipient lumens, staining positively for the luminal marker angiotensin converting enzyme. Antiangiogenic levels of thrombospondin-1 had no measurable effect on the overall level of activity of soluble gelatinases or on urokinase plasminogen activator produced by activated endothelial cells. Coupled with previously published data, these results demonstrate thrombospondin-1 is a multifaceted inhibitor able to block the entire program of dedifferentiation and redifferentiation essential to the formation of new vessels. They also support the contention that the endogenously produced protein contributes to the quiescence of the normal vasculature.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0026-2862
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13-26
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9245640-Animals, pubmed-meshheading:9245640-Capillaries, pubmed-meshheading:9245640-Cattle, pubmed-meshheading:9245640-Cell Aggregation, pubmed-meshheading:9245640-Cell Line, Transformed, pubmed-meshheading:9245640-Cell Movement, pubmed-meshheading:9245640-Cells, Cultured, pubmed-meshheading:9245640-Culture Media, Conditioned, pubmed-meshheading:9245640-Depression, Chemical, pubmed-meshheading:9245640-Endothelium, Vascular, pubmed-meshheading:9245640-Fibroblast Growth Factor 2, pubmed-meshheading:9245640-Fibroblasts, pubmed-meshheading:9245640-Gelatinases, pubmed-meshheading:9245640-Keratinocytes, pubmed-meshheading:9245640-Leukocytes, pubmed-meshheading:9245640-Membrane Glycoproteins, pubmed-meshheading:9245640-Muscle, Smooth, Vascular, pubmed-meshheading:9245640-Neovascularization, Physiologic, pubmed-meshheading:9245640-Thrombospondins, pubmed-meshheading:9245640-Urokinase-Type Plasminogen Activator
pubmed:year
1997
pubmed:articleTitle
Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1.
pubmed:affiliation
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois, 60611, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.